Avidity Partners Management »

Axonics Modulation Technolog shares owned by Avidity Partners Management

Quarter-by-quarter ownership of Axonics Modulation Technolog (AXNX) shares owned by Avidity Partners Management from 13F filings

Historical chart of Avidity Partners Management investment in Axonics Modulation Technolog

Tip: Access up to 7 years of quarterly data

All positions including Axonics Modulation Technolog held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axonics Modulation Technolog by Avidity Partners Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $19M 380k 50.47
2019-12-31 $5.8M 208k 27.71

More positions owned by Avidity Partners Management

Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Medtronic SHS (MDT)
Boston Scientific Corporation (BSX)
Oruka Therapeutics (ORKA)
Bristol Myers Squibb (BMY)
Natera (NTRA)
Danaher Corporation (DHR)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Perspective Therapeutics Com New (CATX)
Jade Biosciences Com New (JBIO)
Pfizer (PFE)
Thermo Fisher Scientific (TMO)
Context Therapeutics (CNTX)
Genmab A/s Sponsored Ads (GMAB)

View all positions for Avidity Partners Management